News
Strategies to Eradicate Transmission of Poliovirus and Paralytic Poliomyelitis
Strategies to Eradicate Transmission of Poliovirus and Paralytic Poliomyelitis March 23, 2022 Introduction Polio (poliomyelitis) is a highly infectious disease that mostly affects children under 5 years of age. The causative agent, poliovirus, replicates in the gut but in some cases can invade the central nervous system and cause permanent paralysis (approximately one in 200…
Read MoreGlobal Virus Network Adds the Aegis Consortium as Newest Center of Excellence
Baltimore, Maryland, USA, March 23, 2022: The Global Virus Network (GVN), representing 69 Centers of Excellence and 11 Affiliates in 37 countries comprising foremost experts in every class of virus causing disease in humans and some animals, and the Aegis Consortium at the University of Arizona Health Sciences announced today the induction of Aegis as…
Read MoreGVN Adds the Centre Scientifique de Monaco as Newest Member to Combat Viral Threats
Baltimore, Maryland, USA, March 22, 2022: The Global Virus Network (GVN), representing 69 Centers of Excellence and 11 Affiliates in 37 countries comprising foremost experts in every class of virus causing disease in humans, and the Centre Scientifique de Monaco (CSM) announced CSM as GVN’s newest Affiliate. “Just last year, we co-hosted a significant international…
Read MoreIs Bradykinin Involved in Covid-19 Pathogenesis?
Is Bradykinin Involved in Covid-19 Pathogenesis? March 18, 2022 Inflammation One of the hallmarks of Covid-19 disease is inflammation, mediated in part by overproduction of inflammatory cytokines. However, the mechanisms of such inflammatory process have not been clearly understood. In the past year the potential role of bradykinin, a small peptide and a members of…
Read MoreOngoing Outbreaks of Lassa Virus in Nigeria
Ongoing Outbreaks of Lassa Virus in Nigeria March 8, 2022 Context The first known confirmed Omicron (B.1.1.529) infection was from a specimen collected on November 9, 2021 in Botswana (1). The variant rapidly began to spread to South Africa and other Southern African countries. Nigeria also experienced daily surge of COVID-19 cases in December, and…
Read MoreGVN Announces Inaugural Participants of Postdoctoral Fellowship Program
The three awardees will receive training and mentorship to help support and propel their rising careers in virology BALTIMORE, MD, March 8, 2022: The Global Virus Network (GVN), a coalition comprised of human and animal virologists from 68 Centers of Excellence and 10 Affiliates in 36 countries, today announced the three inaugural members of the GVN Postdoctoral…
Read MoreA Statement from the Global Virus Network on the 2022 Russian Invasion of Ukraine
BALTIMORE, MD, March 2, 2022: The Global Virus Network (GVN) is an apolitical global organization comprised of the world’s leading scientists, including those from Russia and Ukraine, who specialize in education and research for the purpose of protecting mankind from viral proliferation and viruses that cause pandemics.  The scientists of the Global Virus Network collaborate to alleviate…
Read MoreResponse to A Recent Outbreak of Nipah Virus in India in the context of COVID-19 pandemic
February 24, 2022 Context India experienced a devastating second wave of COVID-19 between February and early May of 2021. Since then, cases have declined gradually. Interestingly, the southern Indian state of Kerala accounted for more than half of the country’s new COVID-19 infections this summer, but Kerala has one of India’s lowest COVID-19 fatality rates…
Read MoreGlobal Virus Network (GVN) Adds the Centre for the AIDS Programme of Research in South Africa (CAPRISA) as Newest Member to Combat Viral Threats
Baltimore, Maryland, USA, February 8, 2021: The Global Virus Network (GVN), representing 68 Centers of Excellence and 10 Affiliates in 36 countries comprising foremost experts in every class of virus causing disease in humans, and the Centre for the AIDS Programme of Research in South Africa (CAPRISA) in Durban announced the addition of CAPRISA as GVN’s…
Read MoreCell-Mediated and Innate Immunity Against SARS-CoV-2: What is Known
Cell-Mediated and Innate Immunity Against SARS-CoV-2: What is Known January 26, 2022 Titers of neutralizing antibodies (nAbs) against SARS-CoV-2 have proven a reasonable predictor of protection against infection and disease. However, T cell responses (CD8+ and CD4+), innate immune mechanisms, and Fc-mediated cellular cytotoxicity can also provide protective immunity against the virus. T cells The…
Read More